ArticleBMC cancer2025

Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy.

Khadija Arif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.